Skip to main content
Premium Trial:

Request an Annual Quote

NEWSBRIEF: Orchid, Merck Partner to Study Pharmacogenomics

NEW YORK, May 1 - Orchid BioSciences said today that its GeneShield business has inked a pharmacogenomic partnership with Merck unit Merck-Medco.


The deal calls for the partners to conduct a retrospective clinical pharmacogenomic study of asthma patients undergoing care in a managed care setting.


Click here for more information.